Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Barry Hafkin Advancis Pharmaceutical Names Chief Scientific Officer Barry Hafkin, M.D., has been appointed chief scientific officer at Advancis Pharmaceutical. Located in Germantwon, Md., Advancis is a pharmaceutical company focused on the development and commercialization of drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. In this role, Dr. Hafkin serves on the Advancis Pharmaceutical senior leadership team and is responsible for establishing overall scientific vision and direction for the company, overseeing all research and development functions. With more than 20 years of experience in medicine, Dr. Hafkin most recently was director of virology and immunology for Boehringer Ingelheim Pharmaceuticals. Dr. Hafkin has a bachelor’s degree in chemistry from the University of Houston. He received his medical degree from the University of Texas Medical Center at San Antonio. After completing a medical internship and residency in San Antonio, Dr. Hafkin served as an epidemiologic intelligence service officer at the Centers for Disease Control and Prevention, where he worked in the viral disease branch. Dr. Hafkin also completed a prestigious post-doctoral fellowship with National Institutes of Health funding at Stanford University Medical Center, where he studied the immune response of patients chronically infected with the hepatitis B virus. Arthur J. Higgins Former Enzon Chairman and CEO to Head Bayer HealthCare Arthur J. Higgins, former chairman and CEO of Enzon Pharmaceuticals, has been appointed chairman of the Bayer HealthCare Executive Committee. Mr. Higgins, 48, is replacing Rolf Classon, 58, who is retiring at the end of this month after 13 years of service with Bayer. Bayer HealthCare, a unit of Bayer AG, Leverkusen, Germany, discovers and manufactures innovative products to diagnose, prevent, and treat disease. Mr. Higgins had been chairman and CEO of Enzon Pharmaceuticals since 2001 and previously was president of Abbott’s Pharmaceutical Products Division. He also serves as chairman of the Biotech Council of New Jersey and is on the board of the National Pharmaceutical Council. Mr. Higgins remains as Enzon’s chairman of the board until the election of his successor. He holds a bachelor of science degree in biochemistry from Strathclyde University in Scotland. Mr. Classon has been chairman of the Bayer HealthCare Executive Committee since 2002. Dr. Rebecca A. Taub Roche Appoints VP, Research, Metabolic Diseases Roche, the U.S. pharmaceutical affiliate of F. Hoffmann-La Roche, a leading research-based healthcare company based in Basel, Switzerland, has appointed Rebecca A. Taub, M.D., as VP of research, metabolic diseases. In this new position, Dr. Taub reports to Lee Babiss, Ph.D., VP of preclinical research and development. She is responsible for creating the short- and long-term strategy for metabolics at the company’s U.S. pharmaceutical affiliate in Nutley, N.J., and the company’s global metabolics strategy. In addition, she works with the members of the Nutley research senior team in support of managing the entire site’s portfolio of projects. Dr. Taub joins Roche from Bristol-Myers Squibb, where she was executive director of biology responsible for neuroscience and obesity research. She began her career in academic research, followed by roles of increasing responsibility in drug discovery at DuPont Pharmaceutical, later acquired by Bristol-Myers Squibb. Dr. Taub received her bachelor’s degree from Yale College and her medical degree from Yale University, School of Medicine. She completed her residency at Yale-New Haven Hospital and her postdoctoral fellowship at Harvard Medical School. Dr. Taub was a Howard Hughes Investigator and tenured professor of genetics at the University of Pennsylvania. She has been an invited lecturer at more than 40 conferences and has authored more than 100 publications. Biotech POOL Rodger Currie Rita Norton Amgen Names VP, Government Affairs Amgen, a biotechnology company located in Thousand Oaks, Calif., has named Rodger Currie VP of government affairs. Mr. Currie works with David Beier, Amgen’s senior VP of global government affairs, to create and design the appropriate legislative strategy for the company and is responsible for executing that strategy in Washington, D.C. Mr. Currie joins Amgen from the Pharmaceutical Research and Manufacturers of America (PhRMA), where he most recently was senior VP for federal affairs and law. Mr. Currie led PhRMA’s successful efforts to enact the Best Pharmaceuticals for Children Act in 2001, which aims to improve the safety and efficacy of pharmaceuticals for children, and the Prescription Drug User Fee Act in 2002, which re-authorized the U.S. Food and Drug Administration (FDA) to collect fees from companies that produce certain human drug and biological products in exchange for the FDA’s agreement to meet drug-review performance goals that emphasize timeliness. Before joining PhRMA, he worked as majority counsel for the Committee on Energy & Commerce Republicans in the U.S. House of Representatives, as an attorney in private practice and as a law clerk in the U.S. Attorney’s Office. Mr. Currie earned his J.D. and B.A. degrees from Georgetown University. He replaces Rita Norton, who has retired from Amgen. She remains on staff during the next several months to ensure a seamless transition and has agreed to continue working with Amgen’s government affairs team in a consulting role. Dr. Jeffrey A. Jeddeloh Orion Genomics Promotes to Fill Biomarker Discovery and Detection Director Position Orion Genomics has promoted Jeffrey A. Jeddeloh, Ph.D., to director of biomarker discovery and detection. Orion Genomics, St. Louis, is a research and development biotechnology company dedicated to the discovery, development, and commercialization of products and services that leverage proprietary DNA methylation technologies. Dr. Jeddeloh leads a team of scientists working to discover and develop sensitive assays capable of detecting epigenetic biomarkers that are linked to important human diseases. His team initially focuses on the development of molecular tests that enable the early detection of cancer. He joins Orion from the U.S. Army where he served as a principal investigator at the U.S. Army Medical Research Institute of Infectious Diseases. Dr. Jeddeloh received his doctorate in molecular genetics from Washington University in St. Louis, where he published the molecular isolation and characterization of the first eukaryotic DNA methylation regulatory factor, DDM1, in Nature Genetics. Todd Pierce Genentech Names VP, Corporate Information Technology Genentech has promoted Todd Pierce to VP of corporate information technology (CIT). Genentech, South San Francisco, Calif., is a leading biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for significant unmet medical needs. In this role, Mr. Pierce continues to manage Genentech’s CIT group, including information technology, strategy, planning, application development, operations, and networking. In addition, he chairs the company’s IT strategy council. Mr. Pierce joined Genentech in May 2002 as senior director, CIT operations, and was promoted to the head of CIT in October 2002. He also helped form the IT Strategy Council, a cross-functional team of senior executives who coordinate and set direction for all of the company’s IT activities. Before joining Genentech, Mr. Pierce was chief information officer and director of information systems for the Santa Clara County Social Services Agency. He has more than 15 years of IT leadership experience from a broad range of industries, including commercial software products, health insurance, clinical care, and government. Mr. Pierce holds a bachelor of arts in economics and finance from Austin College and a master of arts in health policy and administration from the University of California, Berkeley. Dr. Raymond J. Tesi Cellerant Therapeutics Names Clinical Development and Medical Affairs Head Raymond J. Tesi, M.D., has joined Cellerant Therapeutics as executive VP of clinical development and medical affairs. Cellerant Therapeutics, Palo Alto, Calif., is a clinical-stage biotechnology company developing a portfolio of products based on the application and regulation of components of the hematopoietic (blood-forming) system. Dr. Tesi formerly was senior VP of clinical development and medical affairs at SangStat Medical. He received his transplantation surgical fellowship training at Ohio State University Hospital, where he was on the staff for five years. Dr. Tesi has been clinically active in kidney, pancreas, liver, and small-bowel transplantation. Dr. Tesi has authored or presented 139 journal articles and abstracts in many areas of solid organ transplantation. He received his M.D. from the Washington University School of Medicine. Biopharmaceutical POOL Dr. Daniel J. Burge Trubion Names Senior VP of Clinical Development Trubion Pharmaceuticals has named Daniel J. Burge, M.D., as senior VP of clinical development. Seattle-based Trubion is a biopharmaceutical company focused on the discovery and development of novel medicines to treat inflammatory diseases and cancer. Dr. Burge is responsible for developing and implementing clinical and regulatory strategies for bringing products to market. Before joining Trubion, Dr. Burge was VP of development at Amgen, where he was responsible for the direct management of the anti-inflammatory product portfolios. Dr. Burge earned his B.A. in chemistry from Taylor University and his doctorate of medicine from Jefferson Medical College, Thomas Jefferson University. He completed his residency at the Department of Internal Medicine at Medical Center of Delaware and was a fellow in the Department of Rheumatology at Hahnemann University Hospital. Dr. David Christ Dr. John G. Fort Adolor Announces Executive Appointments Adolor has appointed David Christ, Ph.D., to VP of preclinical development and John G. Fort, M.D., to VP of medical affairs. Adolor, Exton, Pa., is a biopharmaceutical company specializing in the discovery, development, and commercialization of prescription pain-management products. In the newly created position of VP of preclinical development, Dr. Christ is responsible for overseeing the following departments: drug metabolism and pharmacokinetics, process chemistry, safety assessment, and the newly formed pharmaceutical technologies department. Dr. Christ previously was senior director, drug metabolism and pharmacokinetics at Adolor. Dr. Christ earned his M.S. and his doctorate in pharmacology from the Medical University of South Carolina and his B.S. in pharmacy from University of Maryland School of Pharmacy. In the newly created position of VP of medical affairs, Dr. Fort is responsible for the medical-information group, field-based scientific personnel, and the development and implementation of Phase IV clinical programs. Dr. Fort previously was VP of arthritis and pain, global medical affairs, at Pharmacia. Dr. Fort earned his MBA from Temple University and his doctorate in medicine at the University of Valencia Faculty of Medicine. R. Ray Cummings Dr. Peter D. O’Hanley AVI BioPharma Expands Management Team AVI BioPharma has appointed R. Ray Cummings as VP of business development and Peter D. O’Hanley, Ph.D., M.D., as senior VP of clinical development and regulatory affairs. AVI BioPharma, Portland, Ore., develops drugs to treat life-threatening diseases using third-generation antisense technology and cancer vaccines. Mr. Cummings most recently was the founder and president of Cummings Consulting, where he assisted clients in developing successful business strategies and establishing partnerships for the development and commercialization of therapeutic products and pharmaceutical technologies. Mr. Cummings received his master’s degree in business administration from the University of California, Berkeley. He received a master of science degree from Harvard University in biochemistry and molecular biology and a bachelor of science degree in biological sciences from Stanford University. Dr. O’Hanley previously served as VP of clinical development at Maxygen, where he was responsible for clinical-trial design, strategic regulatory affairs, and implementation of infectious disease and oncology vaccine development programs. He received his Ph.D. and M.D. degrees from the Medical University of South Carolina and completed his master’s degree in public health at the University of California, Berkeley. K. Alice Leung BioMedicines Appoints President and CEO BioMedicines, Emeryville, Calif., has appointed K. Alice Leung as president and CEO. BioMedicines is a biopharmaceutical company focused on developing therapies for cancer and infectious diseases. Before this appointment, Ms. Leung was VP, general manager, of the oncology business unit at Berlex Laboratories. She is a graduate of the University of Western Ontario, and she received her MBA from the Johnson School of Management, Cornell University. Device/Diagnostic POOL Dr. Donald S. Kaplan Protein Polymer Names President and Chief Operating Officer Protein Polymer Technologies has appointed Donald S. Kaplan, Ph.D., as president and chief operating officer. Protein Polymer Technologies is a San Diego-based company focused on developing bioactive products to improve medical and surgical outcomes. Dr. Kaplan, 57, has served as Protein Polymer Technologies’ senior advisor, adhesives and sealants, since April 2003, directing product development for the surgical adhesive and sealant program. Previously, Dr. Kaplan was senior VP of operations and technology at United States Surgical (now a subsidiary of Tyco). He holds a B.S. from Fairleigh Dickenson University, a Ph.D. in polymer chemistry from Adelphi University, and he was a postdoctoral fellow in chemical engineering at the California Institute of Technology. Michael Koch Fujirebio Diagnostics Promotion Fills VP, Operations, Position Fujirebio Diagnostics (FDI), a leader in in vitro diagnostics, has promoted Michael Koch to VP of operations. Mr. Koch, an industry veteran with more than 30 years of experience, previously held the position of director of materials and manufacturing at FDI. FDI, Malvern, Pa., is a subsidiary of Tokyo-based Fujirebio. In his new role, Mr. Koch oversees the company’s manufacturing operations, facilities management, and information technology infrastructure. He is responsible for meeting profit and loss goals for the division, Food and Drug Administration regulations, and good manufacturing practices. Before joining FDI in 1986, Mr. Koch worked with Delmed, overseeing the production of devices for the management of end-stage renal disease dialysis patients. He also worked for nearly a decade in various manufacturing management positions for Johnson & Johnson. Mr. Koch is certified in production and inventory management by the American Production and Inventory Control Society. Michael R. Minogue Abiomed Appoints President and CEO Abiomed has named Michael R. Minogue CEO, president, and member of the board. Abiomed, Danvers, Mass., develops, manufactures, and markets innovative cardiac assist and replacement systems. The planned succession was initiated by founder Dr. David M. Lederman, who remains as chairman and continues to focus his efforts on technology development and strategic collaborations. Mr. Minogue joins Abiomed following a career at GE Medical Systems, where most recently he was VP and general manager of Americas sales and marketing for GE Medical Systems Information Technology He graduated from United States Military Academy at West Point with a B.S. in engineering and earned his MBA at the University of Chicago. John Y. Yoon Paradigm Medical Names CEO Paradigm Medical Industries has appointed John Y. Yoon as president and CEO. Salt Lake City-based Paradigm Medical develops, manufactures, and markets surgical and diagnostic high-tech, proprietary equipment, and consumable products for the medical industry. Mr. Yoon, 40, joins Paradigm Medical from 3Com, where he was senior director of marketing, enterprise voice division. Mr. Yoon earned a B.A. in economics from Harvard College and a MBA in marketing and international business from Duke University. Discovery POOL Dr. Douglas L. Cole Julie S. Iwashita Affymax Appoints VP, Development, and Director of Clinical Development Affymax has expanded its management team with the addition of Douglas L. Cole, Ph.D., as VP of development and Julie S. Iwashita as director of clinical development. Affymax, Palo Alto, Calif., is a drug discovery and development company that is creating novel peptide drugs for the treatment of cancer, immune-mediated, and related diseases. Dr. Cole most recently was VP of technical development with Isis Pharmaceuticals. He also was director of chemical affairs with Marion Merrell Dow; a research chemist and associate director, process analytical development with Merck Sharp & Dohme Research Labs; and a group leader and principal research scientist with Lederle Laboratories. He has a Ph.D. in organic chemistry from the University of Illinois at Champaign and a B.S. in chemistry from Fort Hays State University in Hays, Kansas. Ms. Iwashita has 20 years of industry experience managing clinical trials. Most recently she was with Genitope as project manager, medical affairs. Before Genitrope, she was with Amgen as assistant manager, clinical affairs. She has a B.A. in human biology from Stanford University. CRO POOL Laurel Avery Chiltern International Announces Key U.S. Appointment Chiltern International, a London-based independent clinical research organization, has signaled its intent to become a major player in the United States with the appointment of Laurel Avery as a business development executive. With specific responsibility for the east coast, Ms. Avery helps to maintain the company’s consistent growth in the region in addition to working on projects with existing Chiltern clients. She has joined Chiltern from the conference industry, where she worked in the pharmaceutical sector and was responsible for creating content for conferences on a variety of pharmaceutical topics. Chiltern has U.S. offices in Carlsbad, Calif., Atlanta, and Austin, Texas. Gretchen Haig Bruce Hicks Thomas Wells Integrium Announces Additions to Management Team Integrium, a CRO based in Tustin, Calif., has announced several key additions to its management team, which reflect an expansion of Integrium’s service capabilities, infrastructure, and in-house expertise. Gretchen Haig has been promoted to director of project management from her position as senior project manager. Ms. Haig directs the activities of project managers, ensuring that clients receive coordination and organizational focus. She received her MBA from the University of California, Irvine, and her B.S. in chemical engineering from California State University, Long Beach. She is actively involved in several clinical-research associations and has co-authored a number of articles in biomedical journals. Bruce Hicks has joined Integrium as director of data management. This position was created with the establishment of data management as a separate division, which bolsters Integrium’s data-management capabilities. He is responsible for directing activities of the data-management division and ongoing development of the service line to meet the evolving needs of the industry. Mr. Hicks is a member of the Society for Clinical Data Management. He holds a B.A. in biology. Thomas Wells has joined Integrium as director of information technology. He is charged with overseeing the implementation of multiple enhancements, including the validation of information technology systems in accordance with an accepted standard, System Development Life Cycle (SDLC) model. He oversees the management of all information-technology programs carried out within the company, including the administration of regulatory compliance activities for its software and computer systems. He earned a M.S. degree in biochemistry from the University of California Riverside, with an emphasis in computer science. He holds a B.S. degree in biomedical computing from the Rochester Institute of Technology. Hollie Kounalis Dr. Lynn Shemanski Elena Te Axio Research Names Project Director, Director of Biostatistics, and Data Coordinator Supervisor Axio Research, a Seattle-based CRO, has named Hollie Kounalis as a project director. In this new role she heads project teams, providing statistical, data management, and clinical support to various projects. Ms. Kounalis also oversees project-team operations. Ms. Kounalis has three years of experience as a clinical database developer at Amgen (formerly Immunex) and spent one year at Dendreon as a clinical database contractor. Lynn Shemanski, Ph.D., has been named director of biostatistics at Axio. Dr. Shemanski’s responsibilities include performing sample size calculations for Phase II and Phase III clinical trials, authorship of statistical analysis plans, statistical sections of protocols, and final statistical reports. She also serves as independent DMC statistician for a Phase III clinical trial in Parkinson’s disease. Before joining Axio in 2002, Dr. Shemanski was a senior biostatistician at Cell Therapeutics and had been a research scientist at the University of Washington. She earned her Ph.D. in biostatistics at the University of North Carolina at Chapel Hill and her master’s in statistics from the University of California at Berkley. In other company news, Axio has hired Elena Te as data coordinator supervisor. She provides oversight of data coordination and data technician groups, as well as maintaining data coding libraries and developing databases. Ms. Te previously was at Berlex as a data-management coordinator and at Amgen (formerly Immunex) as a clinical-data analyst. Gena Reed Paragon Biomedical Promotes to Fill President Position Paragon Biomedical has promoted Gena Reed to president. Paragon Biomedical, Irvine, Calif., is a CRO specializing in the management of Phase II-IV clinical trials in a wide range of therapeutic areas. In this new position, Ms. Reed is responsible for all day-to-day operations of the company. Before being named president, she was executive VP, with responsibilities for strategic operations, client relations, and clinical operations. The promotion adds quality operations, business services, information technology, human resources, and administration to her current areas of responsibility. Ms. Reed, as one of the founders of Paragon in 1989, has performed most of the job functions in the company. At various times, she has had responsibility for sales and marketing, finance, and human resources. She holds a B.S. in business administration from the University of Cincinnati. Ms. Reed has extensive experience in the pharmaceutical industry. Before Paragon, she worked in pharmaceutical sales management, consumer products sales management, and human resources at Merrell National, Merrell Dow, and Marion Merrell Dow. While at Merrell Dow, she was one of five individuals selected to start a new health promotion business. In 1998, she received the Orange County Ernst and Young Entrepreneurs of the Year Award for Healthcare. Service POOL Barbara Bochese Ron Collins Cara DiNorcia Jamie Drenocky John Knutila Larry Moran Solara Adds Six to Staff Solara, a provider of strategic-marketing services that help to improve patient access to pharmaceutical brands competing in managed markets, has announced six additions to its rapidly expanding staff. Solara, Parsippany, N.J., is a unit of CommonHealth, a WPP Group company. Barbara Bochese has been hired as an account supervisor. She directs the development and implementation of marketing activities for assigned accounts and also is responsible for contributing to new business development. Before joining Solara, Ms. Bochese was the president of TALK Marketing. Ron Collins has joined Solara as director, account operations. In this position, he oversees account management processes, including proposal coordination and resource allocation and also manages the unit’s finances. Previously, he was employed with PDI as director, contract administration. Cara DiNorcia has joined the company as an assistant account executive. Ms. DiNorcia provides support to Solara’s account-management team by overseeing the daily marketing activities of her assigned accounts, including production of marketing materials. Jamie Drenocky has been hired as an account supervisor. She and Ms. Bochese direct the development and implementation of marketing activities for assigned accounts. Previously, Ms. Drenocky was employed as an account executive with Current Medical Directions. John Knutila has been hired as a senior copywriter. He is charged with developing copy for the agency’s marketing materials and other business communications. Previously, he worked as a senior copywriter at Roska Direct. Larry Moran has been hired as director, marketing systems and solutions. He supervises the agency’s existing technology products and service offerings, develops innovative technical solutions based on clients’ needs, and maintains relationships with the agency’s technology development partners. Before joining Solara, he was VP of marketing and business development with Econium. Gary Foster Wolters Kluwer Health Appoints President and CEO of Medical Research Unit Chicago-based Wolters Kluwer Health, a division of Wolters Kluwer NV, has named Gary Foster president and CEO of the global medical research division, which includes Ovid and Lippincott Williams & Wilkins (LWW) journal publishing. Wolters Kluwer Health provides information for professionals and students in medicine, nursing, allied health, pharmacy, and the pharmaceutical industry. Mr. Foster brings more than 20 years of experience in the healthcare and IT sectors, with a focus on software and services. Most recently, he served as president and CEO of PatientKeeper, a software company that provides a leading platform to enable enterprisewide deployment of handheld computing devices in the healthcare marketplace. Mr. Foster also worked at General Electric Medical Systems, where he led the successful restructuring of an east coast region in the United States and then led growth activities that helped to nearly double the size of the services businesses to $1.2 billion over six years. He holds a bachelor of arts degree from American University and a MBA from the Wharton School of the University of Pennsylvania. Lauren Gaffney Joan Garcia Timothy O’Donnell Dimensional HealthCare Organizational Changes Enhance and Strengthen Staff A promotion and two hires have been announced Dimensional HealthCare (DHC), a provider of community-based medical research to the pharmaceutical and medical-device industries located in Cedar Knolls, N.J. Lauren Gaffney has been promoted to senior VP of client services. A key player at DHC for more than seven years, she has continued to accept increasing levels of responsibility with the company. In this new position, Ms. Gaffney has overall responsibility for the account services, creative services, and tele-operations teams, and she continues to provide a high level of expertise and personal attention to client’s project needs. Joan Garcia has joined the DHC team as VP of account and creative services. Ms. Garcia brings more than 20 years of experience in medical communications and education to DHC. Previously, Ms. Garcia served at PGI’s Scientific Solutions & Communications, where she was the VP of medical communications. All account and creative services staff report directly to Ms. Garcia. She attended the St. Mary’s School of Nursing and was a paramedic for eight years before entering the medical-education business. Timothy O’Donnell has joined DHC as corporate controller. His responsibilities include ensuring that the company’s financial systems and processes provide clients with the information necessary to easily track their projects. He joins the company from the Stepan Company, a chemical manufacturer, where he spent the last 17 years in various financial positions. The DHC finance, human resources, and IT departments report to Mr. O’Donnell. He received his B.S. in accounting from Illinois State University, a CPA certificate from Illinois, and a master of arts in corporate and public communications in the MBA track from Seton Hall University Kelly Gratz Blue Diesel Names President Kelly Gratz has been promoted to president of Blue Diesel, an interactive communications company located in Columbus, Ohio, and subsidiary of inChord Communications. As president, Ms. Gratz is responsible for directing the company’s operations and overseeing business development. Ms. Gratz, who joined Blue Diesel in 2000 as chief operating officer, has 15 years of experience in the business and technology fields in project management, strategy, consulting, and professional services. During the past four years, she has led many of Blue Diesel’s client relationships and has managed the agency’s staffing and internal structure. Before joining the company, Ms. Gratz worked for Symix Systems. Ms. Gratz holds a bachelor’s degree from the University of Dayton. Rob Kinslow Seidler Bernstein Fills VP, Communications, Position through Promotion Seidler Bernstein, a full-service marketing and communications agency specializing in healthcare and life sciences, has promoted Rob Kinslow to VP of communications from senior director, communications. Mr. Kinslow joined the Cambridge, Mass., agency in 1999 as creative director, copy. A former president of the American Medical Writers Association New England Chapter, Mr. Kinslow is a veteran medical writer and public relations specialist. Keith Loehlein Maureen McLaughlin Sue Ramspacher NOP World Health Appoints Leaders for Three New Practice Areas NOP World Health has named Keith Loehlein, Maureen McLaughlin, and Sue Ramspacher to head its three new practice areas: assessment and tracking, promotional effectiveness, and consumer as patient. A supplier of primary research to the global healthcare community, NOP World Health, East Hanover, N.J., is the health-focused arm of NOP World, a subsidiary of U.K.-based United Business Media. In these new roles, Mr. Loehlein, Ms. McLaughlin, and Ms. Ramspacher are charged with driving product innovation and best-practice solutions across a focused set of pharmaceutical marketing, market research, and sales-management applications. Mr. Loehlein was named senior VP of assessment and tracking. He leads the assessment and tracking practice, which includes NOP World Health’s therapeutic class studies on more than 50 disease states, as well as the company’s new market event research. He has joined NOP World Health from SureScripts, where he served as VP, drafting the strategic plan for pharmaceutical services. As senior VP of promotional effectiveness, Ms. McLaughlin’s duties include overseeing the ScripDriver productivity tool, in addition to NOP World Health’s promotional testing, message recall, and sales optimization services. She has joined NOP World Health from Solucient, where she was senior VP and general manager of the pharmaceutical business unit. Ms. Ramspacher has been named senior VP, consumer as patient, which includes DTC Monitor, the industry’s first tool for assessing and tracking consumer awareness, perceptions, and response to DTC advertising. The consumer as patient area also works closely with its sister business units, NOP World Consumer and Mediamark Research, to adapt proven consumer segmentation, profiling, targeting, and media models to the pharmaceutical industry. Previously, she had been senior VP, portfolio management, at the company. Before coming to NOP World Health, she was VP of client relations at Barnett International. Richard Lyew Access Worldwide Promotes to Fill Executive VP, CFO Position Access Worldwide Communications, a marketing services company, has announced that Richard Lyew, senior VP and corporate controller, will succeed John Hamerski as executive VP and chief financial officer on July 1, 2004. Mr. Lyew joined Access Worldwide, Boca Raton, Fla., in May 1998 as assistant corporate controller. He was promoted the following year to senior VP and corporate controller. Before joining Access Worldwide, Mr. Lyew spent more than six years in public accounting at PricewaterhouseCoopers where he participated in acquisitions, divestitures, roll-ups, and initial public offerings, along with performing audit and tax work. He is a certified public accountant licensed in the state of New York and a member of the American Institute of Certified Public Accountants. Nancy Pope Nelson Solucient names CEO Solucient, Evanston, Ill., a provider of strategic business and clinical information for the healthcare industry, has named Nancy Pope Nelson as CEO. Ms. Nelson succeeds Charles Leonard, who continues to serve on the Solucient board and as a senior advisor to the company. Ms. Nelson brings more than 20 years of experience as a senior executive in both public and private corporations in the information technology, healthcare, and financial-services industries. Most recently, Ms. Nelson served as chief operating officer with Micro General. Before that position, she was chief operating officer at Quadramed, a healthcare software and services company. Ms. Nelson holds a B.S. in biological sciences from the University of California, Irvine. Additionally, she has completed extensive graduate coursework in mathematics and computer science at California State University, Long Beach. She is licensed by the state of California Department of Health Services as a clinical laboratory scientist and holds national certification with the American Society of Clinical Pathologists. Michael C. Pinto Octagon Research Solutions Names VP of Sales Octagon Research Solutions, King of Prussia, Pa., a provider of regulatory, clinical-information management, process, and information-technology products and services to the life-sciences industry, has appointed Michael C. Pinto as VP of sales. Mr. Pinto directs the global sales effort for Octagon’s suite of creative technology products and services designed to support the complex electronic regulatory submission development process. He has more than 14 years of business development and software sales experience within the life-sciences and related industries. Most recently, he was VP of strategic sales at I-MANY, a solution software company. Before I-MANY, Mr. Pinto worked for Bristol-Myers Squibb, Wyeth, and Accenture, where he led teams developing competitive advantage through the adoption of enabling technology. Mr. Pinto received his master of business administration from New York University’s Leonard N. Stern School of Business and a bachelor of arts degree in economics and business from Lafayette College. Gregg Sweet Integrated Clinical Trial Services Names VP Integrated Clinical Trial Services (ICTS) has named Gregg Sweet as the company’s VP of development. ICTS, Cary, N.C., is a full-service patient-enrollment firm that provides clinical-trial sponsors, contract research organizations, and site networks with a comprehensive resource for patient-recruitment expertise. In this position, he is responsible for business, product, and corporate development, establishing relationships with industry experts in an effort to identify new business opportunities and solutions. Additionally, he is charged with developing tools to address business-related obstacles. Mr. Sweet has 10 years of patient-recruitment experience and 30 years of experience in media and advertising. Dr. Tom Young Connextions Health Appoints Senior VP and Corporate Medical Director Connextions Health, Orlando, Fla, has appointed Tom Young, M.D., to senior VP and corporate medical director. Connextions Health provides complete care coordination and population health-management solutions for healthcare organizations. Dr. Young oversees all day-to-day and quality control operations for Connextions Health. He is charged with ensuring that all population health management and care-coordination activities are evidence-based, clinically sound, and deliver projected outcomes. Dr. Young has more than 30 years of experience as a family practice physician, healthcare administrator, and industry consultant. Before joining Connextions Health, Dr. Young served as medical director for Medicaid in the State of Idaho. In addition, he served as medical director for the Medicare Quality Improvement Organization in Idaho and the associate director of the Family Practice Residency of Southwest Idaho. Dr. Young holds a bachelor of arts from Austin College and M.D. from University of Texas-Galveston. David Zaritsky Harte-Hanks Names Managing Director to Lead Sales in Pharmaceutical Market David Zaritsky has joined Harte-Hanks as the new managing director, pharmaceutical market. He is in charge of all direct marketing sales to pharmaceutical and life-sciences clients. Harte-Hanks, San Antonio, is a worldwide direct and targeted marketing company that provides direct-marketing services and shopper advertising opportunities to a wide range of local, regional, national, and international consumer and business-to-business marketers. Mr. Zaritsky, based in the company’s Langhorne, Pa., office, has 13 years of experience in pharmaceutical markets. Most recently, he served as VP of sales with Promex Medical, a drug-sampling service provider. He also has served as a national sales trainer and product specialist at Cypros Pharmaceuticals, as a regional manager at Wilson Cook Medical, and as a professional product representative at Roche. Mr. Zaritsky is a graduate of the State University of New York-Stony Brook. Mr. Zaritsky replaces Mitch Bednar, who now focuses solely on the retail market, as managing director at Harte-Hanks. Medical-Education POOL Joan Alexander- Bascome Betti Barrows Sudip Biswas Dr. George Brown Deana Capalbo-Ference Cheryl Doto Dr. Jeff Kramer Marie Miller Jennifer Ostrow Carol Pierini Maria Pollaro Eric Ratinetz Fred Sheeler Christopher Trill David Winkler Health Learning Systems Announces Promotions and Appointments As part of an internal reorganization to address immense growth resulting from a series of recent new business wins, Health Learning Systems (HLS), CommonHealth’s founding medical-education unit located in Wayne, N.J., has announced promotions and appointments. CommonHealth is a healthcare-communications resource and a WPP Group company. Joan Alexander-Bascome has joined HLS as a senior VP of program management and is responsible for overseeing the unit’s program department. Before joining HLS, she was VP of account management at Thomson Physicians World, and was most recently, group account director at The Scienomics Group. Betti Barrows has been appointed executive VP of operations. Ms. Barrows is responsible for the development and delivery of HLS business. She works with company management and staff to create new services and expand existing capabilities. Ms. Barrows joins HLS from Thomson Physicians World, where she was employed for more than 20 years, serving most recently as executive VP of operations. Sudip Biswas, MBA, has started with HLS as senior director of program planning and development. He is responsible for the overall management of the program teams supporting his assigned accounts. Previously, Mr. Biswas was a senior director of program management at MPE Communications. George Brown, Ph.D., has been promoted to assistant VP of professional relations from associate medical director for HLS. In this position, Dr. Brown assists the VPs in his department with new business development for the unit. Deana Capalbo-Ference has been named meeting coordinator. In this role, she plans and facilitates speaker’s bureau programs for her assigned accounts. Before joining HLS, she was a manager of the speaker’s bureau at Integrated Communications. Cheryl Doto has moved to program director from associate program director. In this new role, she is responsible for developing the educational content of her clients’ programs, recruiting faculty, and serving as a liaison between account management and medical direction on content issues and agenda development. Jeff Kramer, Pharm.D., has joined HLS as a senior medical director for the unit. In this role, he provides direction of medical content for ongoing and new business activities while maintaining strong relationships with thought leaders and managing less senior-level medical directors and writers. Dr. Kramer previously served as VP of medical services at Ingenix Health Education. Marie Miller has been promoted to senior VP of professional relations from VP of professional relations. In this capacity, Ms. Miller focuses on identifying and cultivating new business opportunities for HLS, as well as orchestrating the overall management of the unit’s client relationships. Jennifer Ostrow has joined HLS as a program coordinator and ensures timely program development, traffics all stages of program elements, and follows up with faculty and sponsor approval on all materials. Ms. Ostrow earned a B.A. from Lehigh University. Carol Pierini has joined HLS as the unit’s newest program director and works to drive the development of the educational content on her client accounts. Most recently, Ms. Pierini worked as a healthcare consultant at TriGenesis Communications. Maria Pollaro has been promoted to director of meetings management at HLS. She had been senior meetings manager for the unit. Ms. Pollaro continues to handle all of the logistics associated with the planning and execution of live events and serves in a supervisory role within the meeting planning department. Eric Ratinetz has joined HLS as VP of professional relations. Mr. Ratinetz is responsible for building upon existing client relationships and identifying new business opportunities for HLS. Before joining the unit, he was a senior consultant for Campbell Alliance. Fred Sheeler has joined HLS as a medical word processor, a position that entails creating and editing both presentation graphics programs and text documents for on-site meetings in support of the unit’s program directors. Mr. Sheeler previously was employed with UMS Group. Christopher Trill has been named an account manager for the unit. His responsibilities include participating in new business development research and partnering with his unit team to ensure that client expectations are met and exceeded wherever possible. Before coming to HLS, Mr. Trill worked as an account manager at Medical Action Communications. David Winkler has been promoted to VP of professional relations at HLS. Previously, he was assistant VP of professional relations. He is responsible for developing existing client relationships and identifying new business opportunities for the unit. Christa Dardaganian Dr. Heather DeGrendele Stacy Melville Cadent Medical Communications Announces New Hires Cadent Medical Communications, a medical-education and communication company based in Irving, Texas, has recently added to its staff. Cadent is a subsidiary of inChord Communications. Christa Dardaganian has been named account executive. She is responsible for handling all aspects of client services, including new business and project management. Before joining Cadent, she served as senior account manager at MediTech Media. She holds a master’s degree from Emerson College and a bachelor’s degree from the University of California, Irvine. Heather DeGrendele, Ph.D., has been named medical writer. She is responsible for slide set development, medical writing, and editing. Previously, Dr. DeGrendele served as assistant managing editor/medical writer at PER, Cancer Information Group. She holds a Ph.D. from University of Texas Southwestern and a bachelor’s degree from the University of Texas at Austin. Stacy Melville has been named account executive. She is responsible for coordinating marketing ventures with pharmaceutical companies. Previously, Ms. Melville served as sales and marketing representative at Vitas Hospice and a sales and marketing representative for Eli Lilly. She holds a bachelor’s degree from the University of Texas at Austin. Bill Ferrell Carmen Johnson Columbia MedCom Group Announces Promotions The Columbia MedCom Group (CMCG), Columbia, Md., has announced two staff promotions. Bill Ferrell has been promoted to account group supervisor, new accounts team, and Carmen Johnson has been promoted to account supervisor of the Guilford Pharmaceuticals’ team. The Columbia MedCom Group comprises two wholly owned subsidiaries: INNOVIA Education Institute and Medicalliance. In this new role, Mr. Ferrell oversees the Eisai/Pfizer, Ortho-McNeil, and Guilford Pharmaceutical accounts. Mr. Ferrell joined Medicalliance in January 1996 as the manager of project services. Before joining the company, he spent more than 15 years in the advertising and design industry. In her previous role, Ms. Johnson helped enhance CMCG’s managed-care programming and oversaw a wide variety of initiatives for neurology clients. Ms. Johnson joined the company last year after 13 years in the pharmaceutical advertising and medical-education arena. She previously was the VP, director of program development, for Medical Education Group Consulting POOL Dr. Robert W. Makuch MetaWorks Names Chief Scientific Advisor MetaWorks has named Robert W. Makuch, Ph.D., as chief scientific advisor. MetaWorks, Medford, Mass., is a healthcare consulting company focused in clinical drug development and commercialization within the pharmaceutical, biotechnology, and healthcare industries. Dr. Makuch works collaboratively with Susan Ross, M.D., MetaWorks’ cofounder, to expand scientific and advisory offerings of the company, which brings a wide range of epidemiological, statistical, and meta-analysis expertise and successful regulatory experience to each client engagement. As a consultant to the senior-management team, in addition to steering activities related to the execution of consulting projects for MetaWorks, Dr. Makuch provides general and project-specific scientific oversight and direction to clinical and statistical staff. Dr. Makuch holds a master’s and Ph.D. degree from Yale University and is a prolific author and frequent conference speaker. Ted Mannen President and CEO Chosen to Lead Aventor Aventor, the health advocacy and medical consulting firm affiliated with the law firm of Baker and Daniels, has named Ted Mannen president and CEO. Mr. Mannen has led Aventor’s healthcare reimbursement consulting group since June 2001. He heads up an experienced team of senior executives at the Washington, D.C.-based company. Mr. Mannen’s nearly 30 years of government affairs experience includes serving as a lawyer for the U.S. Senate and House, as well as in senior management positions at the Health Industry Manufacturers Association (now AdvaMed). During his 18 years at HIMA, his positions included general counsel; senior VP of government affairs; senior VP of policy and communications; and executive VP of healthcare systems. Technology/Web POOL Faith Anderson LeeAnn Collins Diane Hollman Monitorforhire.com Expands Sales Team Faith Anderson, LeeAnn Collins, and Diane Hollman have joined Monitorforhire.com as account executives. Monitorforhire.com is an Internet-based resource management company that matches clinical-trial sponsors with prescreened, qualified, independent clinical monitors around the world. The company has offices in Philadelphia and San Diego. Ms. Anderson is responsible for sales in the Mid-Atlantic region. Before joining the company, she served as clinical account manager with a Philadelphia-based staffing firm. In this role with the company, Ms. Collins manages sales for the western region. She previously worked with Cytyc as a medical sales specialist. Ms. Hollman is responsible for handling southeast regional sales. Before joining the monitorforhire.com team, Ms. Hollman was with PRA International, where she served as manager of business development. Nicolas Barthelemy Karen Gibson Invitrogen Appoints Experienced Executives to Improve Operations Invitrogen, Carlsbad, Calif., a provider of life-sciences technologies for disease research and drug discovery, has appointed Nicolas Barthelemy as senior VP of global operations and Karen Gibson as senior VP of information technology and chief information officer. Mr. Barthelemy has international experience and cross-functional skills in the biotech and pharmaceutical industries. His focus is on improving Invitrogen’s resources for streamlining global operations to increase quality and value to customers. Most recently, he was VP of manufacturing and general manager of the Research Triangle Park, N.C., site for Biogen. He holds a combined degree in math, physics, and chemistry from Ecole Sainte Genevieve and has a master of science degree in chemistry from the Ecole Superieure de Physiques et Chimie Industrielles, both in France. He also holds a masters of science in chemical engineering from the University of California at Berkley. He has completed the program for management development at Harvard Business School. Ms. Gibson’s focus is on implementing global information-technology programs. She has proven global leadership coupled with an extensive technical background. Most recently, she was VP of global e-business and chief information officer for General Electric’s Medical Systems Information Technologies division. She holds a B.S. in computer technology from Purdue University and a MBA from Ohio University. Dr. Karen Moore BioPoint Solutions Appoints Chief Science Officer Karen Moore, Ph.D., has been named chief science officer at BioPoint Solutions, a provider of technology solutions and professional services for the biotechnology and pharmaceutical industries located in Danvers, Mass. Dr. Moore is responsible for overseeing the practical, science-based application of the company’s flagship data-management and workflow enforcement solution, DiscoverTrac, and related service offerings. She has more than 22 years of experience in the life-sciences industry. Most recently, Dr. Moore was a consultant for Etiologics. She Moore has authored more than 60 publications and was a named inventor on 13 patents. Mark A. Thierer President of Physicians Interactive Selected Allscripts Healthcare Solutions, a provider of clinical software, connectivity, and information solutions for physicians, has named Mark A. Thierer president of the Physicians Interactive business unit. Mr. Thierer leads the strategic expansion of Physicians Interactive’s business model into new markets within the pharmaceutical and managed-healthcare marketplace and shepherds the introduction of a number of new products and services. Before joining Physicians Interactive, Libertyville, Ill., Mr. Thierer spent 10 years at CaremarkRx, serving in a number of senior operating roles. Mr. Thierer holds a MBA and a B.S. in finance. Association POOL Dr. Pamela Bush Reed McManigle David Palmer Pittsburgh Life Sciences Greenhouse Bolsters Management Team With Staff Promotions The Pittsburgh Life Sciences Greenhouse (PLSG), a partnership to put Pittsburgh’s life-sciences on a fast track for growth, has bolstered its management team. Pamela Bush, Ph.D., has been promoted to investment programs manager. She works to manage PLSG’s portfolio of financing programs. Dr. Bush, who joined the PLSG in November 2002, was program associate. Before joining the PLSG, she was a consultant for LaunchCyte. She earned her doctorate in biological sciences from Carnegie Mellon University, and she received her bachelor’s degree in biology from Florida International University. Reed McManigle has been promoted to director of investment programs and incubation services. He oversees all PLSG financing programs and the PLSG Incubator. Mr. McManigle, who joined the PLSG in July 2003, was director of incubator and entrepreneurial services. Before joining the PLSG, he was technology licensing manager at the University of Pittsburgh. He earned his MBA degree from Carnegie Mellon University, a law degree from the University of Pennsylvania, and a B.A. from the University of Dayton. David Palmer has been appointed chief operating officer. He oversees all the day-to-day operations of the PLSG and provides support to the president and CEO. Mr. Palmer joined the PLSG team in February 2003 as VP of business development. Before joining the PLSG, he was CEO of Confirmant, a life-sciences joint venture company formed by Marconi and Oxford Glycosciences. He earned his master’s degree in public management from Carnegie Mellon University and his bachelor’s degree from West Virginia University. Michelle Collier Stephen Mason GPhA Names Director of Federal Government Affairs and Director of Events The Generic Pharmaceutical Association (GPhA) has appointed Michelle Collier as director of events and Stephen Mason as director of federal government affairs. GPhA, Arlington, Va., represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Ms. Collier brings more than 14 years of experience to GPhA that includes conference administration, event planning, travel consultation, and account management. Before joining GPhA, she was the conference administrator at Walton Thomas International. Ms. Collier received her B.A. from the University of California at Berkeley. Most recently, Mr. Mason was the federal legislative director and political action committee director for the Health Insurance Association of America. Mr. Mason received his B.S. from Oakland University. Dr. David W. Feigal Jr. Dr. Daniel Schultz Dr. Doug Throckmorton Promotions and Resignations Announced at FDA Dr. David W. Feigal Jr. has left the Food and Drug Administration after a successful and productive tenure in various senior positions, most recently as the director of Center for Devices and Radiological Health (CDRH). He has left to continue his distinguished career in the medical community in Phoenix. Since being named director, CDRH, in 1999, Dr. Feigal has worked with Congress and industry to launch a medical device user fee program that has laid the groundwork for CDRH’s product approval program in the years to come. Throughout his FDA service, Dr. Feigal has maintained an active interest in world health affairs by representing the agency as a steering committee member for the Global Program on AIDS, the International Conferences on Harmonization, and the Tripartite Meetings. He has served as a FDA representative and contributor to numerous workshops and conferences at the National Academy of Sciences. Daniel Schultz, M.D., director of CDRH’s Office of Device Evaluation, is serving as acting CDRH center director and heads up a management team that provides continuity for CDRH’s many programs and ongoing initiatives. Dr. Schultz attended the City College of New York and received his medical degree from the University of Pittsburgh. Doug Throckmorton, M.D., has been appointed as acting deputy center director of the FDA’s Center for Drug Evaluation and Research (CDER) division, Rockville, Md. Dr. Throckmorton is a board-certified internist and nephrologist. He received his M.D. from the University of Nebraska Medical School, served his internship and residency at Case Western Reserve University. He then completed clinical and research fellowship programs in nephrology at the Yale-New Haven Hospital. Dr. Throckmorton spent several years as an academic nephrologist at the VA Medical Center and the Medical College of Georgia. He joined CDER in 1997 as a medical officer in the division of cardiorenal drugs, later was appointed as the deputy director, and most recently as the division director in 2002. He replaces Dr. Mark Goldberger, who held the position for the past six months. Media POOL Jim McCarthy Joe Schuldner Tim Wolfinger Biolink Bolsters Team Biolink Communications, a medical publishing and education company with expertise in oncology communications, has hired Jim McCarthy as its executive editor and strengthened its salesforce by naming Joe Schuldner as the company’s director of sales and marketing and Tim Wolfinger as its group sales manager. Biolink is based in Huntington, N.Y. Mr. McCarthy brings more than three decades of oncology editing experience to the company. He was founder and long-time editorial director of the journal Oncology. He also has served as editor of the journals Oncology News International and Primary Care & Cancer. Mr. McCarthy, as well as Mr. Schuldner and Mr. Wolfinger, join Biolink from CMP Healthcare Media’s Oncology Publishing Group. Guy Pawlak National Sales Manager Hired for The Female Patient Guy Pawlak has joined Quadrant HealthCom as national sales manager for The Female Patient. Quadrant HealthCom, Chatham, N.J., is a medical publisher that produces journals in the primary-care and specialty-care fields. He joins The Female Patient with more than 12 years of advertising and medical-education sales experience. Mr. Pawlak previously was at Advanstar Medical Economics, where he spent the last eight years selling pages, projects, and custom CE supplements for the leading nursing journal, RN. M. Kerry Robinson Patient Care Hires Senior Account Manager M. Kerry Robinson has been named senior-account manager on Patient Care, a monthly clinical publication that helps physicians provide effective and efficient care for their patients. Published by Advanstar Medical Economics, New York, Patient Care focuses on practical issues in clinical care covering topics in cardiology, infectious diseases, and drug therapy. Most recently, Mr. Robinson worked at Triple I Oncology where he was responsible for selling and managing the company’s oncology business. Agency POOL Kim Carpenter Regina Eustaquio Dr. Stephanie Ganz Greg Lewis John McGarry Dr. Adena Svingos Sudler & Hennessey Announces Additions to Staff Staff additions have been announced at varios divisions of Sudler & Hennessey, a New York-based agency and part of The S&H Group, a global healthcare marketing and communications organization. Avenue-e Health Strategies, the eMarketing division of Sudler & Hennessey, has hired Kim Carpenter as client-services director. Previously, she was with IconNicholson, where she was the director of the user experience group. Among her various responsibilities at Avenue-e, is the development of interactive patient and physician communication initiatives in partnership with the Sudler & Hennessey network of companies. IntraMed West, a medical-education division of Sudler & Hennessey located in San Francisco, has added Regina Eustaquio as director of client services. Ms. Eustaquio has more than 16 years of experience in healthcare marketing, communications, and medical education. Before taking the position with IntraMed West, Ms. Eustaquio held the dual role of director, client services, and director, educational programs, at Vox Medica/CoMed Communications. In the New York office of IntraMed, Stephanie Ganz, M.D., has been hired as an associate medical director. Dr. Ganz most recently was a research associate with New York Presbyterian Hospital, Cornell Medical Center. She also has been a research assistant in the Department of Psychology at Emory University. Dr. Ganz received her medical degree from New York Medical College. Greg Lewis has been hired as an account group supervisor at Sudler & Hennessey in New York. Mr. Lewis is responsible for the management of several brands from Roche Laboratories. John McGarry has been named director, creative support services, a new position at Sudler & Hennessey, New York. Mr. McGarry reports to Louisa Holland and Jim Metropoulos, copresidents of Sudler & Hennessey. Mr. McGarry has more than 14 years of experience in production and creative services with DP Consulting and at Bozell Worldwide. Adena Svingos, Ph.D., joins IntraMed as a scientific associate. Dr. Svingos had been at Weill Medical College of Cornell University where she was on the faculty in the neurology and neuroscience department. She received her Ph.D. in neuroscience from the State University of New York, Stony Brook. Jennifer Cullen Diana DiMenna Rob Gordon Donald Poracky Jason Ross Jennifer Tindal Craig Yarwood Adient Announces New Hires and Promotions Adient, located in Wayne, N.J., has announced new hires and promotions. Adient is the professional healthcare advertising agency of CommonHealth, a healthcare-communications resource and a WPP Group company. Jennifer Cullen has been promoted to senior account executive from account executive. In this new position, she continues to oversee the development and implementation of professional marketing materials for her assigned accounts. Diana DiMenna has been hired as a VP, group copy supervisor. Before joining Adient, Ms. DiMenna was involved in freelance work for a variety of healthcare products. Rob Gordon has joined Adient as an account group supervisor. He comes to the agency from Andrx Laboratories, where he served as product manager and was responsible for launching the pharmaceutical company’s first branded product. Donald Poracky has joined Adient as a group copy supervisor. Previously, he was a consultant in the managed-care communications field. Additionally, in this career he has held senior-level positions at Lowe Bozell McAdams and Lowe McAdams Healthcare. Jason Ross has been promoted to senior account executive from account executive. In his new position, Mr. Ross continues to oversee the development and implementation of professional marketing materials for his assigned accounts. Jennifer Tindal joins the agency as an account executive. Previously, she was an assistant account executive at Torre Lazur McCann. Craig Yarwood has joined the advertising agency as a VP, account group supervisor. Previously, he served as VP, account group supervisor at Interlink Healthcare Communications. PharmaVoice welcomes comments about this article. E-mail us at [email protected].

Download PDF